Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
Pavan P. Adiseshaiah, Rachael M. Crist, Sara S. Hook, et al.
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 12, pp. 750-765
Open Access | Times Cited: 215

Showing 51-75 of 215 citing articles:

Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy
Ming Jia, Dan Zhang, Chunxiang Zhang, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Development of Non-Porous Silica Nanoparticles towards Cancer Photo-Theranostics
Chihiro Mochizuki, Junna Nakamura, Michihiro Nakamura
Biomedicines (2021) Vol. 9, Iss. 1, pp. 73-73
Open Access | Times Cited: 44
Regulation of tumor microenvironment for pancreatic cancer therapy
Xu Huang, Lei Ding, Xingkai Liu, et al.
Biomaterials (2021) Vol. 270, pp. 120680-120680
Closed Access | Times Cited: 43
Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer
Yao Xiao, Wenxia Yao, Mingzhen Lin, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1712-1725
Open Access | Times Cited: 33
Supramolecular materials based on AIEgens for photo-assisted therapy
Xin‐Yue Lou, Ge Zhang, Nan Song, et al.
Biomaterials (2022) Vol. 286, pp. 121595-121595
Closed Access | Times Cited: 28
A review on reactive oxygen species (ROS)-inducing nanoparticles activated by uni- or multi-modal dynamic treatment for oncotherapy
Jinyong Lin, Dong Li, Changhong Li, et al.
Nanoscale (2023) Vol. 15, Iss. 28, pp. 11813-11833
Closed Access | Times Cited: 17
Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistance
Liying Wang, Xiangrui Liu, Quan Zhou, et al.
Biomaterials (2017) Vol. 144, pp. 105-118
Closed Access | Times Cited: 60
Recent advancements in 2D nanomaterials for cancer therapy
Menghuan Li, Zhong Luo, Yanli Zhao
Science China Chemistry (2018) Vol. 61, Iss. 10, pp. 1214-1226
Closed Access | Times Cited: 57
Nanoparticle-based drug delivery systems: What can they really do in vivo?
Yi-Feng Wang, Lu Liu, Xue Xue, et al.
F1000Research (2017) Vol. 6, pp. 681-681
Open Access | Times Cited: 55
Melanin-based nanoparticles in biomedical applications: From molecular imaging to treatment of diseases
Xinyu Wang, Jie Sheng, Min Yang
Chinese Chemical Letters (2018) Vol. 30, Iss. 3, pp. 533-540
Closed Access | Times Cited: 55
Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancer
Vijay Sagar Madamsetty, Krishnendu Pal, Sandeep Keshavan, et al.
Nanoscale (2019) Vol. 11, Iss. 45, pp. 22006-22018
Closed Access | Times Cited: 49
Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes
Xiaoxiao Chen, Qianwen Yu, Yinke Liu, et al.
Acta Biomaterialia (2019) Vol. 99, pp. 339-349
Closed Access | Times Cited: 46
In Vivo Real-Time Pharmaceutical Evaluations of Near-Infrared II Fluorescent Nanomedicine Bound Polyethylene Glycol Ligands for Tumor Photothermal Ablation
Shengliang Li, Haoting Chen, Haile Liu, et al.
ACS Nano (2020) Vol. 14, Iss. 10, pp. 13681-13690
Closed Access | Times Cited: 46
Nanobiohybrids: A Synergistic Integration of Bacteria and Nanomaterials in Cancer Therapy
Yuhao Chen, Meng Du, Jinsui Yu, et al.
BIO Integration (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 40
Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review
Gayathri Ravichandran, Aravind Kumar Rengan
ACS Applied Nano Materials (2020) Vol. 3, Iss. 10, pp. 9542-9559
Closed Access | Times Cited: 40
Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
Michelle K. Greene, Michael C. Johnston, Christopher J. Scott
Cancers (2021) Vol. 13, Iss. 24, pp. 6175-6175
Open Access | Times Cited: 40
Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer
Jingjing Sun, Zhuoya Wan, Jieni Xu, et al.
Biomaterials (2020) Vol. 269, pp. 120629-120629
Open Access | Times Cited: 39
The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
Donatella Delle Cave, Riccardo Rizzo, Bruno Sáinz, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 930-930
Open Access | Times Cited: 39
Homotypic Cancer Cell Membranes Camouflaged Nanoparticles for Targeting Drug Delivery and Enhanced Chemo-Photothermal Therapy of Glioma
Yajing Ren, Chenlin Miao, Liang Tang, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 157-157
Open Access | Times Cited: 25
Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems
Cláudia Viegas, Ana B. Patrício, João Prata, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2363-2363
Open Access | Times Cited: 15
Microbiomes in pancreatic cancer can be an accomplice or a weapon
Xiaoyu Guo, Pan Wang, Yuan Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104262-104262
Closed Access | Times Cited: 5
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2
M. Vogt, Nevenka Dudvarski Stanković, Yiliam Cruz Garcia, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1509-1528
Open Access | Times Cited: 5
An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer
Laura Bourillon, C. Bourgier, Nadège Gaborit, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 7, pp. 1838-1851
Open Access | Times Cited: 42
Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
Lei Fan, Xinyuan Xi, Surinder K. Batra, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 370, Iss. 3, pp. 682-694
Open Access | Times Cited: 41
188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept
Chia‐Ming Chang, Keng-Li Lan, Wen-Sheng Huang, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 5, pp. 903-903
Open Access | Times Cited: 40

Scroll to top